Patent Yard Sign in
European application, no grantEurope

Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumours

EP 0885017 A2 · Applicant: MALLINCKRODT MEDICAL, INC.

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Google PatentsEPO PDF

Why it's free to use

  • Filed February 25, 1997 and never granted as a European patent. Had it been granted, its 20-year term would have ended February 25, 2017.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by August 25, 2022.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledFebruary 25, 1997
PublishedDecember 23, 1998
GrantedNever granted
Term endedFebruary 25, 2017
Application numberEP 97908751
Classification (CPC)A61K51/083 +2 more

Timeline

Timeline From EPO dates

1998200020022004200620082010201220142016Application filedFeb 25, 1997PublishedDec 23, 1998Term endedFeb 25, 2017

Sources & verification

Official EPO records

Full published documentClaims, description and drawings as a PDF.EPOEuropean Patent RegisterProcedure, status, file inspection and legal events.EPOLinked open EP data recordThe bibliographic record this page is built from.EPO

Cross-check elsewhere

Google PatentsFull text, worldwide family, citing patents and legal events.patents.google.comEspacenetNational family members and their legal status.European Patent Office

Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.